11 CAR § 25-132. Occupational carpal tunnel syndrome

        11 CAR § 25-132. Occupational carpal tunnel syndrome.

        (a) Authority and purpose.

                (1) Pursuant to Acts 2001, No. 1281, an additional section, Arkansas Code § 11-9-117, has been added to empower the Workers’ Compensation Commission, in accordance with its rulemaking authority, to enact medical diagnostic and treatment guidelines regarding occupational carpal tunnel syndrome.

                (2) These guidelines are based upon the joint recommendation of the Arkansas American Federation of Labor and Congress of Industrial Organization and the Arkansas State Chamber of Commerce.

        (b) Applicability and effective date. This section and the guidelines set forth herein shall be applicable to all claims for workers’ compensation benefits regarding occupational carpal tunnel syndrome filed with the commission on or after September 20, 2001.

        (c) Introduction.

                (1)(A) Carpal tunnel syndrome (CTS) is caused by compression of the median nerve at the wrist.

                        (B) Occupational CTS (OCTS) assumes a work-relatedness.

                (2) Compared to nonoccupational CTS, OCTS patients are:

                        (A) Younger and have generally less severe changes on nerve conduction studies (NCS); and

                        (B) About equally male or female.

                (3) Diabetes, pregnancy, hypothyroidism, and rheumatoid and other inflammatory arthritides are health problems occasionally associated with CTS.

        (d) Diagnosis.

                (1)(A) Initially, patients may have mild, intermittent symptoms usually of a few weeks duration without objective signs of median nerve dysfunction.

                        (B) The intermittent symptoms include numbness, tingling, or pain in the hand that occur with use of the hand and at night.

                        (C) Patients with persistent CTS have objective findings on examination or symptoms that fail to improve with conservative treatment, usually within four (4) weeks.

                (2) Clinical findings.

                        (A) Symptoms:

                                (i)(a) Paresthesia in the hand, usually the first three (3) digits of the hand.

                                        (b) However, patients often do not discriminate between some or all of the digits.

                                        (c) Symptoms appropriate to the median nerve distribution are sensitive, ninety-three hundredths (0.93) or seven percent (7%) false negative, but also have low specificity, twenty-five hundredths (0.25) or seventy-five percent (75%) false positives;

                                (ii) Pain in the hand, forearm, upper arm;

                                (iii) A feeling of weakness or clumsiness of the hand.

                        (B) Signs or objective findings:

                                (i) Decreased sensation in the median nerve distribution (two-point discrimination has a sensitivity of twenty-three hundredths (0.23) but a specificity of eighty-two hundredths (0.82));

                                (ii)(a) Weakness is usually difficult to demonstrate in mild CTS.

                                        (b) Thenar atrophy indicates more severe CTS;

                                (iii) Tinel’s sign (sensitivity = sixty-two hundredths (0.62), specificity = sixty-six hundredths (0.66));

                                (iv) Phalen’s sign (sensitivity = seventy-three hundredths (0.73), specificity = thirty-six hundredths (0.36));

                                (v) Abnormal nerve conduction studies;

                                (vi) Even in patients with NCS-established OCTS, the exam may be normal.

                        (C) If the NCS changes are mild to moderate, conservative management with splinting, medication, and job modification could be continued for four (4) to eight (8) weeks.

                        (D) Surgical decompression of the carpal tunnel (carpal tunnel release) is considered if there is:

                                (i) Failure to improve with conservative management and there are corroborative NCS findings;

                                (ii) Progression of symptoms during conservative management and there are corroborative NCS findings; or

                                (iii) Atrophy or significant NCS abnormality.

                        (E) In general, if a patient has symptoms that are thought to be from OCTS but has no objective verification of OCTS, including no abnormality on NCS, then that patient has likely reached maximum medical improvement at no longer than eight (8) weeks of conservative management under the care of a medical or osteopathic physician.

        (e) Nerve conduction studies.

                (1)(A)(i) Nerve conduction studies are the recognized standard for the diagnosis of CTS.

                                (ii) The following recommended criteria are adapted from those of the State of Washington Department of Labor & Industry.

                                (iii) Other criteria may be utilized as long as such criteria have a sound basis in the peer-reviewed literature.

                        (B)(i) Median palmar latencies (palm to wrist at eight centimeters (8 cm)).

                                (ii) Abnormal latency greater than two and two-tenths milliseconds (> 2.2 msecs).

                                (iii) Median minus ulnar palmar latency abnormal greater than three-tenths milliseconds (> 0.3 msecs).

                        (C)(i) Median motor latency (wrist to APB at eight centimeters (8 cm)).

                                (ii) Abnormal latency greater than four and five-tenths milliseconds (> 4.5 msecs).

                                (iii) Median minus ulnar motor distal latency abnormal greater than one and eight-tenths milliseconds (> 1.8 msecs).

                        (D)(i) Median sensory distal latency (wrist to digit at fourteen centimeters (14 cm)).

                                (ii) Abnormal latency greater than three and five-tenths milliseconds (> 3.5 msecs).

                        (E)(i) Fourth digit sensory distal latency (wrist to digit at fourteen centimeters (14 cm)).

                                (ii) Median minus ulnar sensory latency difference abnormal greater than five-tenths milliseconds (> 0.5 msecs).

                (2)(A)(i) In general, a complete study would include median and ulnar palmar latencies and median and ulnar motor nerve conduction studies, with hand skin temperature greater than thirty degrees (> 30° C).

                                (ii) No more than ten percent (10%) of CTS patients will have normal standard NCS.

                                (iii) These patients likely have mild median nerve impingement that may occur only with use of the hand.

                        (B) EMG is rarely needed for the diagnosis of CTS.

                        (C) If there is prominent concern for cervical radiculopathy, structural studies might be indicated.

        (f) Work relatedness.

                (1)(A) Carpal tunnel syndrome occurs both from intrinsic or patient factors (e.g., small carpal tunnel from arthritis or congenitally, metabolic derangement, etc.) and extrinsic factors, which for occupational CTS would be job activities.

                        (B) That is, if the predominant cause of the CTS is from job activity, then the CTS is work-related.

                (2)(A) Job activity that regularly requires extensive use of the hands may be an appropriate exposure.

                        (B) Such activity involves repetitive hand use, especially:

                                (i) For prolonged periods;

                                (ii) Against force;

                                (iii) With strongly vibrating equipment;

                                (iv) With repeated wrist flexion, extension, deviation, forearm rotation, or constant firm gripping; or

                                (v) With awkward hand or wrist positions.

        (g) Management.

                (1) Initial management.

                        (A) Wrist splinting to maintain the wrist in a neutral position at night and when the hand is engaged in substantial activity.

                        (B) Medication, usually an NSAID.

                        (C) Job modification.

                        (D)(i) Steroid injection into the carpal tunnel may offer short-term improvement, but only twenty-two percent (22%) maintain the improvement (in a nonoccupational CTS setting).

                                (ii) A short, tapering course of oral corticosteroid has been shown to offer significant symptomatic improvement in patients with mild to moderate CTS.

                                (iii) Neurology, 1988, 51:390-393.

                (2) Progress.

                        (A) If there is failure to improve with initial management, or if there is a more severe presentation of pain, swelling, weakness, or numbness, then more aggressive measures may be needed, including nerve conduction studies.

                        (B) Nerve conduction studies (NCS) or specialist referral are obtained when there is:

                                (i) Failure to have improvement of symptoms after four (4) weeks of conservative management;

                                (ii) Progression of symptoms during treatment;

                                (iii) Significant abnormality on examination, especially atrophy; or

                                (iv) Time loss on the job.

                (3) The NCS are likely to be more sensitive if performed when the patient is still engaged in his or her usual occupation under normal working conditions.



	
		
		
		<style type="text/css">
			.csBD4C5ED5{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65}
			.csC7173355{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;}
			.cs7D434CDE{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:bold;font-style:normal;}
			.csB6FC81A3{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:italic;}
		</style>
	
	
		<p class="csBD4C5ED5"><span class="csC7173355">        </span><span class="cs7D434CDE">11 CAR &sect; 25-132. Occupational carpal tunnel syndrome.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (a) </span><span class="cs7D434CDE">Authority and purpose.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (1) Pursuant to Acts 2001, No. 1281, an additional section, Arkansas Code &sect; 11-9-117, has been added to empower the Workers&rsquo; Compensation Commission, in accordance with its rulemaking authority, to enact medical diagnostic and treatment guidelines regarding occupational carpal tunnel syndrome. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                (2) These guidelines are based upon the joint recommendation of the Arkansas American Federation of Labor and Congress of Industrial Organization and the Arkansas State Chamber of Commerce.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (b) </span><span class="cs7D434CDE">Applicability and effective date. </span><span class="csC7173355">This section and the guidelines set forth herein shall be applicable to all claims for workers&rsquo; compensation benefits regarding occupational carpal tunnel syndrome filed with the commission on or after September 20, 2001.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (c) </span><span class="cs7D434CDE">Introduction.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (1)(A) Carpal tunnel syndrome (CTS) is caused by compression of the median nerve at the wrist. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) Occupational CTS (OCTS) assumes a work-relatedness. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                (2) Compared to nonoccupational CTS, OCTS patients are: </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (A) Younger and have generally less severe changes on nerve conduction studies (NCS); and </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) About equally male or female. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                (3) Diabetes, pregnancy, hypothyroidism, and rheumatoid and other inflammatory arthritides are health problems occasionally associated with CTS.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (d) </span><span class="cs7D434CDE">Diagnosis.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (1)(A) Initially, patients may have mild, intermittent symptoms usually of a few weeks duration without objective signs of median nerve dysfunction. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) The intermittent symptoms include numbness, tingling, or pain in the hand that occur with use of the hand and at night. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (C) Patients with persistent CTS have objective findings on examination or symptoms that fail to improve with conservative treatment, usually within four (4) weeks.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (2) </span><span class="cs7D434CDE">Clinical findings.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (A) Symptoms:</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (i)</span><span class="csB6FC81A3">(a)</span><span class="csC7173355"> Paresthesia in the hand, usually the first three (3) digits of the hand. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                        </span><span class="csB6FC81A3">(b)</span><span class="csC7173355"> However, patients often do not discriminate between some or all of the digits. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                        </span><span class="csB6FC81A3">(c)</span><span class="csC7173355"> Symptoms appropriate to the median nerve distribution are sensitive, ninety-three hundredths (0.93) or seven percent (7%) false negative, but also have low specificity, twenty-five hundredths (0.25) or seventy-five percent (75%) false positives;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Pain in the hand, forearm, upper arm; </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) A feeling of weakness or clumsiness of the hand.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) Signs or objective findings:</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (i) Decreased sensation in the median nerve distribution (two-point discrimination has a sensitivity of twenty-three hundredths (0.23) but a specificity of eighty-two hundredths (0.82));</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii)</span><span class="csB6FC81A3">(a)</span><span class="csC7173355"> Weakness is usually difficult to demonstrate in mild CTS. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                        </span><span class="csB6FC81A3">(b)</span><span class="csC7173355"> Thenar atrophy indicates more severe CTS;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Tinel&rsquo;s sign (sensitivity = sixty-two hundredths (0.62), specificity = sixty-six hundredths (0.66));</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iv) Phalen&rsquo;s sign (sensitivity = seventy-three hundredths (0.73), specificity = thirty-six hundredths (0.36));</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (v) Abnormal nerve conduction studies;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (vi) Even in patients with NCS-established OCTS, the exam may be normal.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (C) If the NCS changes are mild to moderate, conservative management with splinting, medication, and job modification could be continued for four (4) to eight (8) weeks.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (D) Surgical decompression of the carpal tunnel (carpal tunnel release) is considered if there is:</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (i) Failure to improve with conservative management and there are corroborative NCS findings; </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Progression of symptoms during conservative management and there are corroborative NCS findings; or</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Atrophy or significant NCS abnormality.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (E) In general, if a patient has symptoms that are thought to be from OCTS but has no objective verification of OCTS, including no abnormality on NCS, then that patient has likely reached maximum medical improvement at no longer than eight (8) weeks of conservative management under the care of a medical or osteopathic physician.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (e) </span><span class="cs7D434CDE">Nerve conduction studies.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (1)(A)(i) Nerve conduction studies are the recognized standard for the diagnosis of CTS. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) The following recommended criteria are adapted from those of the State of Washington Department of Labor &amp; Industry. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Other criteria may be utilized as long as such criteria have a sound basis in the peer-reviewed literature.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B)(i) Median palmar latencies (palm to wrist at eight centimeters (8 cm)). </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Abnormal latency greater than two and two-tenths milliseconds (&gt; 2.2 msecs).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Median minus ulnar palmar latency abnormal greater than three-tenths milliseconds (&gt; 0.3 msecs).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (C)(i) Median motor latency (wrist to APB at eight centimeters (8 cm)). </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Abnormal latency greater than four and five-tenths milliseconds (&gt; 4.5 msecs).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Median minus ulnar motor distal latency abnormal greater than one and eight-tenths milliseconds (&gt; 1.8 msecs).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (D)(i) Median sensory distal latency (wrist to digit at fourteen centimeters (14 cm)). </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Abnormal latency greater than three and five-tenths milliseconds (&gt; 3.5 msecs).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (E)(i) Fourth digit sensory distal latency (wrist to digit at fourteen centimeters (14 cm)).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Median minus ulnar sensory latency difference abnormal greater than five-tenths milliseconds (&gt; 0.5 msecs).</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (2)(A)(i) In general, a complete study would include median and ulnar palmar latencies and median and ulnar motor nerve conduction studies, with hand skin temperature greater than thirty degrees (&gt; 30&deg; C). </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) No more than ten percent (10%) of CTS patients will have normal standard NCS. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) These patients likely have mild median nerve impingement that may occur only with use of the hand. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) EMG is rarely needed for the diagnosis of CTS. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (C) If there is prominent concern for cervical radiculopathy, structural studies might be indicated.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (f) </span><span class="cs7D434CDE">Work relatedness.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (1)(A) Carpal tunnel syndrome occurs both from intrinsic or patient factors (e.g., small carpal tunnel from arthritis or congenitally, metabolic derangement, etc.) and extrinsic factors, which for occupational CTS would be job activities. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) That is, if the predominant cause of the CTS is from job activity, then the CTS is work-related.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (2)(A) Job activity that regularly requires extensive use of the hands may be an appropriate exposure. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) Such activity involves repetitive hand use, especially:</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (i) For prolonged periods;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Against force;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) With strongly vibrating equipment;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iv) With repeated wrist flexion, extension, deviation, forearm rotation, or constant firm gripping; or</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (v) With awkward hand or wrist positions.</span></p><p class="csBD4C5ED5"><span class="csC7173355">        (g) </span><span class="cs7D434CDE">Management.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (1) </span><span class="cs7D434CDE">Initial management. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (A) Wrist splinting to maintain the wrist in a neutral position at night and when the hand is engaged in substantial activity.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) Medication, usually an NSAID.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (C) Job modification.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (D)(i) Steroid injection into the carpal tunnel may offer short-term improvement, but only twenty-two percent (22%) maintain the improvement (in a nonoccupational CTS setting). </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) A short, tapering course of oral corticosteroid has been shown to offer significant symptomatic improvement in patients with mild to moderate CTS. </span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Neurology, 1988, 51:390-393.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (2) </span><span class="cs7D434CDE">Progress.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (A) If there is failure to improve with initial management, or if there is a more severe presentation of pain, swelling, weakness, or numbness, then more aggressive measures may be needed, including nerve conduction studies.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                        (B) Nerve conduction studies (NCS) or specialist referral are obtained when there is:</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (i) Failure to have improvement of symptoms after four (4) weeks of conservative management;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (ii) Progression of symptoms during treatment;</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iii) Significant abnormality on examination, especially atrophy; or</span></p><p class="csBD4C5ED5"><span class="csC7173355">                                (iv) Time loss on the job.</span></p><p class="csBD4C5ED5"><span class="csC7173355">                (3) The NCS are likely to be more sensitive if performed when the patient is still engaged in his or her usual occupation under normal working conditions. </span></p>

“APB” means abductor pollicis brevis.

"EMG" means electromyography.

"NSAID" means nonsteroidal anti-inflammatory drug.

This section as promulgated prior to codification into the Code of Arkansas Rules provided as follows:

"(Approved August 29, 2001; effective September 20, 2001.)"
Arkansas Code § 11-19-117; Arkansas Code § 11-9-207